Emerging Researchers National (ERN) Conference

nsf-logo[1]

  • About
    • About AAAS
    • About the NSF
    • About the Conference
    • Partners/Supporters
    • Project Team
  • Registration
    • Conference Registration
    • Exhibitor Registration
    • Hotel Reservations
  • Abstracts
    • Abstract Submission Process
    • Presentation Schedules
    • Abstract Submission Guidelines
    • Presentation Guidelines
    • Undergraduate Abstract Locator (2020)
    • Graduate Abstract Locator (2020)
    • Faculty Abstract Locator (2020)
  • Travel Awards
  • Resources
    • App
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP/CREST PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • Video Contest
    • Video Contest Winners
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • App View

Evaluation of Gold Nanoparticles Toxicity to Human Epithelial Cells (HEp-2 cells) and Effect on Apoptotic Genes

Undergraduate #277
Discipline: Nanoscience
Subcategory: Nanoscience

Joshua Middleton - Alabama State University
Co-Author(s): Pooja Tiwari, Swapnil Pawage, Erdal Eroglu, Shree R. Singh, and Komal Vig



Nanomaterial has become a leading field of science and its studies are contributing immensely to the creation of: insulation materials, elimination of pollutants, panel displays, more durable cutting tools, high energy density batteries, high-power magnets, high-sensitivity sensors, automobiles with greater fuel efficiency, and even aerospace components. Nanotechnology is providing stimulating new tools and materials to the pharmaceutical industry that have the potential to dramatically improve drug delivery methods. Gold Nanoparticles have tunable optical and electronic properties and are used in a number of applications such as: electronics, photodynamic therapy, therapeutic agent delivery, sensors, probes, diagnostics, and catalysis. In the present study we evaluated PEGylated gold nanoparticle (2025nM in size) toxicity to HEp-2 cells using MTT assay at four concentrations; 0.625nM, 1.25nM, 2.5nM, and 5nM; and, at three time intervals; 24hrs, 48hrs, and 72hrs. Toxicity was also measured using trypan blue cell exclusion assay, using 5nM and 2.5nM at 48hrs. Our results showed that after 24hrs the maximum observed cell death was 10% and, by 72hrs it increased to 15%. We further investigated the effect of gold nanoparticles on apoptotic genes. RNA from nanoparticle incubated HEp-2 cells was extracted and cDNA was synthesized. Primers specific for p53, capsase 3, Bc12, and Bax were used to amplify cDNA using Bio-Rad Master Cycler. Amplified DNA was evaluated for the gene product using agarose gel electrophoresis. Based on our results we can conclude that the addition of gold nanoparticles has little to no toxicity on the HEp-2 cells, essentially allowing for gold nanoparticles to be a carrier for vaccines, diagnostics, and other biomedical applications.

Funder Acknowledgement(s): Center of BioNanotechnology at Alabama State University and the National Science Foundation

Faculty Advisor: Komal Vig,

ERN Conference

Celebrating 10 years of ERN!

What’s New

  • Webinars
  • Events|Opportunities
  • AAAS CEO Comments on Social Unrest, Racism, and Inequality
  • Maintaining Accessibility in Online Teaching During COVID-19
  • In the News
  • #ShutDownSTEM
  • HBCU/CREST PI/PD Meeting

Conference Photos

ERN Conference Photo Galleries

Awards

ERN Conference Award Winners

Checking In

Navigation

  • About the ERN Conference
  • Partners/Supporters
  • Abstracts
  • Travel Awards
  • Conference Registration
  • Exhibitor Registration
  • Hotel Reservations

nsf-logo[1]

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW Washington,DC 20005
202-326-6400
Contact Us
About Us

The World's Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

 

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law
© 2021 American Association for the Advancement of Science